Low testosterone linked to 18% higher risk of dying from cancer

An international study of 26,000 men indicates that low testosterone levels are associated with an 18% higher risk of cancer-related mortality. The research highlights that while testosterone is a factor, other hormones like SHBG are more relevant to prostate cancer risk.
Why it matters
Hormone levels could serve as long-term biomarkers for predicting cancer risk, allowing for earlier preventative health interventions.
Men with very low testosterone levels may face an increased risk of developing cancer and dying from the disease later in life, according to a major international study. The findings suggest that testosterone levels could provide an early clue to future health risks, potentially years or even decades before cancer is diagnosed.
Researchers found that men with low testosterone had an 18 percent higher risk of dying from cancer. However, the relationship was not the same for every type of cancer. Surprisingly, testosterone levels were not associated with prostate cancer risk. Instead, prostate cancer was more closely linked to low levels of two other hormones, sex hormone-binding globulin (SHBG) and luteinizing hormone.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in